½ÃÀ庸°í¼­
»óǰÄÚµå
1304616

µðÁöÅÐ Ä¡·á ½ÃÀå : Á¦Ç° À¯Çüº°, ÆÇ¸Å ä³Îº°, ¿ëµµº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2023-2030³â)

Digital Therapeutics Market with COVID-19 Impact Analysis, By Product Type, By Sales Channel, By Applications, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: AnalystView Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® 295 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

º¸°í¼­ÀÇ ÁÖ¿ä ³»¿ë

µðÁöÅÐ Ä¡·á ½ÃÀå ±Ô¸ð´Â 2022³â 47¾ï 7,100¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2023³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 33.9%·Î È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µðÁöÅÐ Ä¡·á ½ÃÀå - ½ÃÀå ¿ªÇÐ:

ÀÇ·áºñ Àý°¨¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ÇコÄÉ¾î ¿ëµµ°ú ¿¬µ¿µÈ ÅÂºí¸´ ¹× ½º¸¶Æ®ÆùÀÇ »ç¿ë Áõ°¡, ÇコÄɾî Àü °úÁ¤ÀÇ ÀÌÁ¡, ¸¸¼ºÁúȯ ¹ßº´·ü Áõ°¡´Â ¼¼°è µðÁöÅÐ Ä¡·á ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ±×·¯³ª Ä¡·á¿ë Á¦Ç°¿¡´Â À߸øµÈ Á¤º¸¿Í °úµµÇÑ ¿¹Ãø °á°ú µîÀÇ ÇѰ谡 ÀÖ¾î µðÁöÅÐ Ä¡·á ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

¶ÇÇÑ, ȯÀÚ¿Í ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü¸¦ À§ÇÑ µðÁöÅÐ ÀÇ·á ±â¼úÀÇ ºñ¿ë È¿À²¼º, ÅëÇÕ ÀÇ·á ½Ã½ºÅÛ¿¡ ´ëÇÑ ¿ä±¸ Áõ°¡, ȯÀÚ Áß½É Ä¡·á´Â µðÁöÅÐ Ä¡·á ½ÃÀå¿¡ Å« ±âȸ¸¦ Á¦°øÇÏ´Â µ¥ ±â¿©Çϰí ÀÖÀ¸¸ç, Äڷγª19 ÆÒµ¥¹ÍÀº µðÁöÅÐ Ä¡·á ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. Á¤½ÅÁúȯÀÇ À¯º´·ü Áõ°¡, µðÁöÅÐ °Ç°­ÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄ, ¼¼°è ¾à¹° ³²¿ë·ü Áõ°¡ µîÀÌ ±×°ÍÀÔ´Ï´Ù. ¶ÇÇÑ, ÆÒµ¥¹Í°ú Á¤ºÎÀÇ ¾ö°ÝÇÑ ±ÔÁ¦·Î ÀÎÇØ »ç¶÷µéÀº Áý¿¡ ¸Ó¹°·¯¾ß Çß°í, ÀÌ´Â °Ç°­¿¡ ÇØ·Î¿î »ýȰ ¹æ½Ä, ½Åü Ȱµ¿ °¨¼Ò, Á¤½ÅÀû ½ºÆ®·¹½º·Î À̾îÁ® ¸¸¼º ÁúȯÀÇ »ç·Ê¸¦ Áõ°¡½ÃÄ×À¸¸ç, ÀÌ´Â µðÁöÅÐ Ä¡·á ¼ö¿ä¸¦ Áõ°¡½Ãų °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

µðÁöÅÐ Ä¡·á ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

  • ¼¼°è µðÁöÅÐ Ä¡·á ½ÃÀåÀº Á¦Ç° À¯Çü, ÆÇ¸Å ä³Î, ¿ëµµ ¹× Áö¿ªº°·Î ¼¼ºÐÈ­µË´Ï´Ù.
  • Á¦Ç° À¯Çü¿¡ µû¶ó ½ÃÀåÀº ¼ÒÇÁÆ®¿þ¾î¿Í ÀåÄ¡ µÎ °¡Áö·Î ³ª´¹´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î ºÐ¾ß´Â ¾ÕÀ¸·Îµµ ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. Àå±âÀûÀÎ Çൿ º¯È­¸¦ °¡Á®¿À´Â ¸ÂÃã Ä¡·á¿Í ÇÔ²² ȯÀÚÀÇ º¹¾à ¼øÀÀÀ» µ½½À´Ï´Ù.
  • ½ÃÀåÀº ÆÇ¸Å ä³Î¿¡ µû¶ó ±â¾÷ ´ë ±â¾÷(B2B)°ú ±â¾÷ ´ë ¼ÒºñÀÚ(B2C) µÎ °¡Áö·Î ³ª´µ¸ç, B2B ºÐ¾ß°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÁöºÒÀÚ, °í¿ëÁÖ, ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü »çÀÌ¿¡¼­ µðÁöÅÐ Ä¡·áÀÇ ÀÌÁ¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ ºÐ¾ß ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.
  • ½ÃÀåÀº ¿ëµµº°·Î ´ç´¢º´, ºñ¸¸, ½ÉÇ÷°ü Áúȯ(CVD), ½ÇÁ¦ ÁßÃ߽Űæ°è(CNS) Áúȯ, È£Èí±â Áúȯ, ±Ý¿¬, À§Àå Áúȯ, ±âŸ 7°¡Áö·Î ³ª´¹´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ´ç´¢º´ ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù. ´ç´¢º´ÀÇ Á¤È®ÇÑ °ü¸®¸¦ À§ÇØ ÀÌ Ä¡·áÁ¦°¡ Á¦°øÇÏ´Â ´Ù¾çÇÑ ÀÌÁ¡°ú °ü·ÃÇÏ¿© ¼ö¿ä°¡ Áõ°¡Çϰí ÀÎÁöµµ°¡ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù.

µðÁöÅÐ Ä¡·á ½ÃÀå - °æÀï ±¸µµ:

µðÁöÅÐ Ä¡·á´Â °³ÀÎÈ­µÈ Ä¡·á ÇÁ·Î±×·¥°ú ½ÃÀå ±â¾÷µéÀÌ Ã¤ÅÃÇÑ ´Ù¾çÇÑ Àü·«À¸·Î ÀÎÇØ Áúº´À» ¾Î°í Àִ ȯÀڵ鿡°Ô Áß¿äÇÑ Ä¡·á ¿É¼ÇÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ±â¾÷µéÀÌ Ã¤ÅÃÇÏ´Â Àü·«¿¡´Â Á¦Ç° ½ÂÀÎ, ½ÅÁ¦Ç° Ãâ½Ã, Á¦ÈÞ, °øµ¿ ¿¬±¸, R&D ºñ¿ë, M&A, À¯Åë¸Á °³Ã´ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ ´ç´¢º´, ½ÉÀ庴, ºÒ¾È Àå¾Ö¿Í °°Àº ¸¸¼º Áúȯ Áõ°¡·Î ÀÎÇØ ÁÖ¿ä ¾÷üµéÀº ½ÃÀå¿¡¼­ µðÁöÅÐ Ä¡·á¸¦ Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2023³â 1¿ù ·çÆÎ(Lupin)Àº ÀüüÀû ½ÉÀå °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Ä¡·á ¼Ö·ç¼Ç LYFEÀÇ Ãâ½Ã¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ÀÌ´Â Àεµ¿¡¼­ À¯ÀÏÇÑ Áõ°Å ±â¹Ý Àüü·ÐÀû ½ÉÀå Ä¡·á ÇÁ·Î±×·¥À¸·Î ½ÉÀå ¸¶ºñÀÇ À§ÇèÀ» Å©°Ô ÃÖ¼ÒÈ­ÇÏ°í ½ÉÀ庴 ȯÀÚÀÇ »îÀÇ Áú°ú Ȱ·ÂÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

  • µðÁöÅÐ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ ÀÌ Á¶»ç º¸°í¼­´Â 2022³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ½ÃÀå ±Ô¸ð, CAGR, ÃßÁ¤ ¹× ¿¹Ãø(2023-2030³â)À» Á¦°øÇÕ´Ï´Ù.
  • ÀÌ º¸°í¼­´Â ´Ù¾çÇÑ ºÎ¹®/±¹°¡¿¡ °ÉÃÄ ÀáÀçÀûÀÎ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í µðÁöÅÐ Ä¡·á ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.
  • Àüü º¸°í¼­´Â »õ·Î¿î ÅõÀÚ ±âȸ, ±âÁ¸ ±â¾÷ÀÌ Á÷¸éÇÑ °úÁ¦, µðÁöÅÐ Ä¡·á ½ÃÀå¿¡¼­ Áö¼Ó °¡´ÉÇÑ ¼ºÀå ¿äÀÎÀ» ÆÄ¾ÇÇÕ´Ï´Ù.
  • Äڷγª19°¡ µðÁöÅÐ Ä¡·á ½ÃÀå ±Ô¸ð, ¿¹Ãø, CAGR, ½ÃÀå ¿ªÇп¡ ¹ÌÄ¡´Â ¿µÇâÀº ¿¬±¸ ¹üÀ§¿¡¼­ ÀÚ¼¼È÷ ³íÀǵǸç, Æ÷½ºÆ® Äڷγª µðÁöÅÐ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ ½ÉÃþÀûÀÎ ÅëÂû·Âµµ ´Ù·ç°í ÀÖ½À´Ï´Ù.
  • ÀÌ º¸°í¼­´Â »ç¿ëÀÚ¿¡°Ô µðÁöÅÐ Ä¡·á ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ °üÁ¡À» Á¦°øÇϱâ À§ÇØ µðÁöÅÐ Ä¡·á ½ÃÀå °æÀï ±¸µµ¿Í ÁÖ¿ä Çõ½Å°¡ ºÐ¼®µµ Á¦°øÇÕ´Ï´Ù.
  • º» Á¶»ç´Â ½ÃÀå ±Ô¸ð, ¼ºÀå·ü, ¸Å·Âµµ¸¦ ±âÁØÀ¸·Î ¸ðµç »ê¾÷ ºÎ¹®À» º¥Ä¡¸¶Å·ÇÑ ¼ºÀå Àü¸Á ¸ÅÇÎ ºÐ¼®À» Æ÷ÇÔÇÕ´Ï´Ù.
  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ÀÇ »ó¼¼ÇÑ ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» ÅëÇØ µðÁöÅÐ Ä¡·á ½ÃÀå¿¡¼­ Ȱµ¿ÇÏ´Â ±â¾÷ÀÇ À繫 Á¤º¸ ¹× Àü·«Àû ÀÌ´Ï¼ÅÆ¼ºê¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.
  • ¶ÇÇÑ, ¼¼°è»Ó¸¸ ¾Æ´Ï¶ó Áö¿ªÀû Â÷¿ø¿¡¼­µµ ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀÇ Áß¿äÇÑ ÀμöÇÕº´, Á¦ÈÞ ¹× ÇÕÀÛÅõÀÚ, ½ÅÁ¦Ç° Ãâ½Ã, ¿¬±¸°³¹ß, Áö¿ª ÁøÃâ¿¡ ´ëÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
  • ¼¼°è µðÁöÅÐ Ä¡·á ½ÃÀå º¸°í¼­´Â ÁÖ·Î °ø±Þ¾÷ü, ÅõÀÚÀÚ, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À¯Åë¾÷ü, ±ÝÀ¶ ºÐ¼®°¡ µî ÀÌ ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå µðÁöÅÐ Ä¡·á ½ÃÀå °³¿ä

  • Á¶»ç ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå ³»¿ª
  • °æÀï ÀλçÀÌÆ®

Á¦3Àå µðÁöÅÐ Ä¡·á ÁÖ¿ä ½ÃÀå µ¿Çâ

  • µðÁöÅÐ Ä¡·á ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • µðÁöÅÐ Ä¡·á ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • µðÁöÅÐ Ä¡·á ½ÃÀå ±âȸ
  • µðÁöÅÐ Ä¡·á ½ÃÀå ÇâÈÄ µ¿Çâ

Á¦4Àå µðÁöÅÐ ¿ä¹ý »ê¾÷ Á¶»ç

  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ±ÔÁ¦ ±¸Á¶ ºÐ¼®

Á¦5Àå µðÁöÅÐ Ä¡·á ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

  • COVID-19 ÀÌÀüÀÇ ¿µÇ⠺м®
  • COVID-19 ÀÌÈÄÀÇ ¿µÇ⠺м®

Á¦6Àå µðÁöÅÐ Ä¡·á ½ÃÀå ±¸µµ

  • µðÁöÅÐ Ä¡·á ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â
  • ÁÖ¿ä Á¦Á¶¾÷üº° ºÐ¼® µ¥ÀÌÅÍ
    • ±âÁ¸ ±â¾÷ ºÐ¼®
    • ½Å±Ô ±â¾÷ ºÐ¼®

Á¦7Àå µðÁöÅÐ Ä¡·á ½ÃÀå - Á¦Ç° À¯Çüº°

  • °³¿ä
    • Á¦Ç° À¯Çüº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ¼ÒÇÁÆ®¿þ¾î
    • µð¹ÙÀ̽º

Á¦8Àå µðÁöÅÐ Ä¡·á ½ÃÀå - ÆÇ¸Åä³Îº°

  • °³¿ä
    • ÆÇ¸Åä³Îº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • B2B
    • B2C

Á¦9Àå µðÁöÅÐ Ä¡·á ½ÃÀå - ¿ëµµº°

  • °³¿ä
    • ¿ëµµº° ºÎ¹® Á¡À¯À² ºÐ¼®
    • ´ç´¢º´
    • ºñ¸¸
    • ½ÉÇ÷°üÁúȯ(CVD)
    • ½ÇÁ¦ ÁßÃ߽Űæ°è(CNS) Áúȯ
    • È£Èí±â Áúȯ
    • ±Ý¿¬
    • À§Àå ¹®Á¦
    • ±âŸ

Á¦10Àå µðÁöÅÐ Ä¡·á ½ÃÀå - Áö¿ªº°

  • ¼­·Ð
  • ºÏ¹Ì
    • °³¿ä
    • ºÏ¹ÌÀÇ µðÁöÅÐ Ä¡·á ÁÖ¿ä Á¦Á¶¾÷ü
    • ¹Ì±¹
    • ij³ª´Ù
  • À¯·´
    • °³¿ä
    • À¯·´ÀÇ µðÁöÅÐ Ä¡·á ÁÖ¿ä Á¦Á¶¾÷ü
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ¿µ±¹
    • ÇÁ¶û½º
    • ·¯½Ã¾Æ
    • ³×´ú¶õµå
    • ½º¿þµ§
    • Æú¶õµå
    • ±âŸ
  • ¾Æ½Ã¾ÆÅÂÆò¾ç(APAC)
    • °³¿ä
    • ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ µðÁöÅÐ Ä¡·á ÁÖ¿ä Á¦Á¶¾÷ü
    • Àεµ
    • Áß±¹
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • ű¹
    • Àεµ³×½Ã¾Æ
    • Çʸ®ÇÉ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • °³¿ä
    • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ µðÁöÅÐ Ä¡·á ÁÖ¿ä Á¦Á¶¾÷ü
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ¾Æ¸£ÇîÆ¼³ª
    • ÄÝ·Òºñ¾Æ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • °³¿ä
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ µðÁöÅÐ Ä¡·á ÁÖ¿ä Á¦Á¶¾÷ü
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ÅÍŰ
    • ¾ËÁ¦¸®
    • ÀÌÁýÆ®
    • ±âŸ

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - µðÁöÅÐ Ä¡·á »ê¾÷

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä
    • Click Therapeutics, Inc.
    • Proteus Digital Health, Inc.
    • Pear Therapeutics
    • Welldoc, Inc.
    • 2MORROW, Inc.
    • Happify
    • Fitbit, Inc.(Twine Health, Inc.)
    • Resmed, Inc.(Propeller Health)
    • Medtronic Plc.
    • Kaia Health
    • Akili Interactive Labs, Inc.
    • Livongo Health, Inc.
    • Omada Health, Inc.
    • Voluntis, Inc.

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ ´Ù°¢Àû °ßÇØ

LSH 23.08.16

REPORT HIGHLIGHT

Digital therapeutics market size was valued at USD 4,771.0 Million in 2022, expanding at a CAGR of 33.9% from 2023 to 2030.

Digital therapeutics refers to hardware and software that digitally preserve evidence-based therapeutic actions for the prevention and management of the disease. Additionally, the software and tools support the management of various ailments connected to respiratory, cardiovascular, and mental health issues. Moreover, increasing case of chronic diseases like cancer, heart failure, diabetes, and mental illness is a factor attributed to the rising demand for this market.

Digital Therapeutics Market- Market Dynamics:

The rising requirement to control healthcare costs, increasing use of tablets & smartphones coupled with healthcare applications, advantages of the entire process of healthcare, and rising chronic disease incidence is likely to propel the demand for the global digital therapeutics market. However, therapeutic products have their limitations including false information and over-predictive results which may restrain the market growth of digital therapeutics.

Furthermore, the cost-effectiveness of digital health technologies for patients and providers, the increasing requirement for integrated health systems, and patient-centered care contributed to offering massive opportunities for the digital therapeutics market. The COVID-19 pandemic impacted the digital therapeutics market positively. The increase in the prevalence of mental illness, awareness regarding the importance of digital health, and the increase in the rate of drug abuse worldwide. In addition, during the pandemic and government stringent regulation people had to stay at home, which led to unhealthy lifestyles, less physical activity, and mental stress this in turn increased the case of chronic disease which is anticipated to increase the demand for digital therapeutics.

Digital Therapeutics Market- Segmentation Analysis:

  • The global digital therapeutics market is segmented on the basis of product type, sales channel, applications, and region.
  • The market is divided into two categories based on product type: software and devices. The software sector is likely to maintain its dominance. It assists patients with medication adherence coupled with personalized care that provides long-term behavioral change.
  • The market is divided into two categories based on sales channel: business-to-business (B2B) and business-to-consumers (B2C). The B2B sector is expected to hold the largest market share. The rising awareness among payers, employers, and providers about the advantages of digital therapeutics is attributed to an increase in the demand for this segment.
  • The market is divided into seven categories based on application: diabetes, obesity, cardiovascular disease (CVD), diseases of the actual central nervous system (CNS), respiratory conditions, quitting smoking, gastrointestinal problems, and others. The diabetes sector is likely to possess the market over the forecast period. The rising need and surging awareness are associated with various advantages provided by this therapeutics for the precise management of diabetes.

Digital Therapeutics Market-Competitive Landscape:

For patients with medical conditions digital therapeutics has become an important treatment option due to personalized treatment programs and various strategies adopted y market players, Additionally, the strategies adopted by the market players include, product approval, new product launches, partnership, collaboration, R&D spending, mergers & acquisitions, and distribution network development. Moreover, the rising chronic disease cases such as diabetes, heart disease, and anxiety disorders have prompted key players to pursue digital treatment in the market. For instance, in January 2023, Lupin announced the launch of LYFE, its Digital Therapeutic Solution for Holistic Heart Care. Additionally, it is only evidence-based holistic heart care program in India's, which significantly minimizes the risk of a heart attack and improves quality and vitals of life for cardiac patients.

Key features of the study:

  • This proposed research study on digital therapeutics market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for digital therapeutics market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the digital therapeutics market.
  • Impact of COVID-19 on digital therapeutics market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on digital therapeutics market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the digital therapeutics market, we have also included competitive landscape and key innovator analysis for the digital therapeutics market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the digital therapeutics market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global digital therapeutics market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIGITAL THERAPEUTICS MARKET KEY PLAYERS

  • Click Therapeutics, Inc.
  • Proteus Digital Health, Inc.
  • Pear Therapeutics
  • Welldoc, Inc.
  • 2MORROW, Inc.
  • Happify
  • Fitbit, Inc. (Twine Health, Inc.)
  • Resmed, Inc. (Propeller Health)
  • Medtronic Plc.
  • Kaia Health
  • Akili Interactive Labs, Inc.
  • Livongo Health, Inc.
  • Omada Health, Inc.
  • Voluntis, Inc.

GLOBALDIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE

  • Software
  • Devices

GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

  • Business-to-business (B2B)
  • Business-to-consumers (B2C)

GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATIONS

  • Diabetes
  • Obesity
  • Cardiovascular Disease (CVD)
  • Diseases of the actual Central Nervous System (CNS)
  • Respiratory Conditions
  • Quitting Smoking
  • Gastrointestinal Problems
  • Others

GLOBAL DIGITAL THERAPEUTICS MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

Table of Contents

1. Digital Therapeutics Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Digital Therapeutics Market Snippet by Product Type
    • 2.1.2. Digital Therapeutics Market Snippet by Sales Channel
    • 2.1.3. Digital Therapeutics Market Snippet by Application
    • 2.1.4. Digital Therapeutics Market Snippet by Country
    • 2.1.5. Digital Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Digital Therapeutics Key Market Trends

  • 3.1. Digital Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Digital Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Digital Therapeutics Market Opportunities
  • 3.4. Digital Therapeutics Market Future Trends

4. Digital Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Digital Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Digital Therapeutics Market Landscape

  • 6.1. Digital Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Digital Therapeutics Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2022&2030 (%)
    • 7.1.2. Software
    • 7.1.3. Devices

8. Digital Therapeutics Market - By Sales Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Sales Channel, 2022&2030 (%)
    • 8.1.2. Business-to-business (B2B)
    • 8.1.3. Business-to-consumers (B2C)

9. Digital Therapeutics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 9.1.2. Diabetes
    • 9.1.3. Obesity
    • 9.1.4. Cardiovascular Disease (CVD)
    • 9.1.5. Diseases of the actual Central Nervous System (CNS)
    • 9.1.6. Respiratory Conditions
    • 9.1.7. Quitting Smoking
    • 9.1.8. Gastrointestinal Problems
    • 9.1.9. Others

10. Digital Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Digital Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Digital Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Digital Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Digital Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Digital Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Sales Channel, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Digital Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Click Therapeutics, Inc.
    • 11.2.2. Proteus Digital Health, Inc.
    • 11.2.3. Pear Therapeutics
    • 11.2.4. Welldoc, Inc.
    • 11.2.5. 2MORROW, Inc.
    • 11.2.6. Happify
    • 11.2.7. Fitbit, Inc. (Twine Health, Inc.)
    • 11.2.8. Resmed, Inc. (Propeller Health)
    • 11.2.9. Medtronic Plc.
    • 11.2.10. Kaia Health
    • 11.2.11. Akili Interactive Labs, Inc.
    • 11.2.12. Livongo Health, Inc.
    • 11.2.13. Omada Health, Inc.
    • 11.2.14. Voluntis, Inc.

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦